New combo therapy shows promise in small melanoma trial
NCT ID NCT03276832
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 20 times
Summary
This early-phase trial tested the safety and effectiveness of combining two drugs—imiquimod (a cream that stimulates the immune system) and pembrolizumab (an immunotherapy injection)—in 7 patients with advanced melanoma that had spread. The goal was to see if the combination could help the body fight the cancer better. The study focused on side effects, tumor shrinkage, and how long patients lived without the cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV CUTANEOUS MELANOMA AJCC V6 AND V7 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
Conditions
Explore the condition pages connected to this study.